Exact Mass: 242.1453

Exact Mass Matches: 242.1453

Found 139 metabolites which its exact mass value is equals to given mass value 242.1453, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Selagine

(13Z)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.02,7]trideca-2(7),3,11-trien-5-one

C15H18N2O (242.1419)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents D004791 - Enzyme Inhibitors (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease.

   

(3S,5R,6R,7E)-3,5,6-Trihydroxy-7-megastigmen-9-one

(3E)-4-(1,2,4-trihydroxy-2,6,6-trimethylcyclohexyl)but-3-en-2-one

C13H22O4 (242.1518)


(3S,5R,6R,7E)-3,5,6-Trihydroxy-7-megastigmen-9-one is found in herbs and spices. (3S,5R,6R,7E)-3,5,6-Trihydroxy-7-megastigmen-9-one is a constituent of New Zealand thyme honey (Thymus vulgaris). Constituent of New Zealand thyme honey (Thymus vulgaris). (3S,5R,6R,7E)-3,5,6-Trihydroxy-7-megastigmen-9-one is found in herbs and spices.

   

2-Carboxy-4-dodecanolide

5-octyl-2-oxooxolane-3-carboxylic acid

C13H22O4 (242.1518)


2-Carboxy-4-dodecanolide is found in milk and milk products. 2-Carboxy-4-dodecanolide is a possible latent butter aroma compoun

   

(-)-Huperzine A (HupA)

1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2(7),3,10-trien-5-one

C15H18N2O (242.1419)


   

Huperzine_A

(AfAEA centa notA inverted exclamation markAfasAA inverted exclamation markAfAEAdaggeratrade markAfA centA centa notA inverted exclamation markAA not)-Huperzine A

C15H18N2O (242.1419)


LSM-1581 is a quinolone. (+/-)-Huperzine A is a natural product found in Streptomyces coelicoflavus and Huperzia with data available. D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents D004791 - Enzyme Inhibitors Huperzine A is a sesquiterpene alkaloid isolated from a club moss Huperzia serrata that has been shown to exhibit neuroprotective activity. It is also an effective inhibitor of acetylcholinesterase and has attracted interest as a therapeutic candidate for Alzheimers disease. It has a role as an EC 3.1.1.7 (acetylcholinesterase) inhibitor, a neuroprotective agent, a plant metabolite and a nootropic agent. It is a sesquiterpene alkaloid, a pyridone, a primary amino compound and an organic heterotricyclic compound. It is a conjugate base of a huperzine A(1+). Huperzine A, is a naturally occurring sesquiterpene alkaloid found in the extracts of the firmoss Huperzia serrata. The botanical has been used in China for centuries for the treatment of swelling, fever and blood disorders. Recently in clinical trials in China, it has demonstrated neuroprotective effects. It is currently being investigated as a possible treatment for diseases characterized by neurodegeneration – particularly Alzheimer’s disease. Huperzine A is a natural product found in Phlegmariurus varius, Phlegmariurus tetrastichus, and other organisms with data available. A sesquiterpene alkaloid isolated from a club moss Huperzia serrata that has been shown to exhibit neuroprotective activity. It is also an effective inhibitor of acetylcholinesterase and has attracted interest as a therapeutic candidate for Alzheimers disease. C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease.

   

7,8-Didehydrosophoramine

7,8-Didehydrosophoramine

C15H18N2O (242.1419)


   

(4R)-4-(Hydroxymethyl)-3-(6-methylheptanoyl)dihydro-2(3H)-furanone

(4R)-4-(Hydroxymethyl)-3-(6-methylheptanoyl)dihydro-2(3H)-furanone

C13H22O4 (242.1518)


   
   

Annuionone F

Annuionone F

C13H22O4 (242.1518)


   

Norchanoclavine II

N-Demethylchanoclavine-II

C15H18N2O (242.1419)


   

[1R-(1alpha,2beta,3beta)]-3-Hydroxy-2-(hydroxymethyl)-3-methyl-gamma-methylene-cyclopentanebutanoic acid methyl ester

[1R-(1alpha,2beta,3beta)]-3-Hydroxy-2-(hydroxymethyl)-3-methyl-gamma-methylene-cyclopentanebutanoic acid methyl ester

C13H22O4 (242.1518)


   

Maybridge1_003864

Maybridge1_003864

C12H22N2OS (242.1453)


   

(2Z)-2-Octyl-2-pentenedioic acid

(2Z)-2-Octyl-2-pentenedioic acid

C13H22O4 (242.1518)


   

Huperzine A

(1R,9S,13Z)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.02,7]trideca-2(7),3,10-trien-5-one

C15H18N2O (242.1419)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents Origin: Plant; SubCategory_DNP: Sesquiterpenoids D020011 - Protective Agents D004791 - Enzyme Inhibitors (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease.

   

AKOS015729984

AKOS015729984

C15H18N2O (242.1419)


   

trans-9-hydroxy-8-oxo-3-methyldodecan-4-olide

trans-9-hydroxy-8-oxo-3-methyldodecan-4-olide

C13H22O4 (242.1518)


   

(-)-butane-1,3-diyl 1-((Z)-2-methyl-2-butenoate) 3-isobutyrate

(-)-butane-1,3-diyl 1-((Z)-2-methyl-2-butenoate) 3-isobutyrate

C13H22O4 (242.1518)


   

trans-6-hydroxymethyl-3-methyl-7-oxo-undecan-4-olide

trans-6-hydroxymethyl-3-methyl-7-oxo-undecan-4-olide

C13H22O4 (242.1518)


   

ethyl trans-9,10-epoxy-11-oxoundecanecanoate

ethyl trans-9,10-epoxy-11-oxoundecanecanoate

C13H22O4 (242.1518)


   

trans-8,9-dihydroxy-3-methyldodec-cis-6-en-4-olide

trans-8,9-dihydroxy-3-methyldodec-cis-6-en-4-olide

C13H22O4 (242.1518)


   

tridec-2-enedioic acid

tridec-2-enedioic acid

C13H22O4 (242.1518)


   

(1S,2R,2S,6S)-4-(2-Hydroxy-2,6-dimethyl-5-oxocyclohexyl)-2-methylbutanoic acid

(1S,2R,2S,6S)-4-(2-Hydroxy-2,6-dimethyl-5-oxocyclohexyl)-2-methylbutanoic acid

C13H22O4 (242.1518)


   

(7E)-7-ethyl-4,9-dihydroxyundec-7-ene-3,6-dione

(7E)-7-ethyl-4,9-dihydroxyundec-7-ene-3,6-dione

C13H22O4 (242.1518)


   

Herbarumin II

Herbarumin II

C13H22O4 (242.1518)


   
   
   

(3R,4R,5S,6R)-4-hydroxy-6-((R,E)-3-hydroxy-3-methylpent-1-en-1-yl)-3,5-dimethyltetrahydro-2H-pyran-2-one|3-hydroxy-8-((E)-10-hydroxy-10-methylpentenyl)-2,4-dimethyltetrahydropyranone

(3R,4R,5S,6R)-4-hydroxy-6-((R,E)-3-hydroxy-3-methylpent-1-en-1-yl)-3,5-dimethyltetrahydro-2H-pyran-2-one|3-hydroxy-8-((E)-10-hydroxy-10-methylpentenyl)-2,4-dimethyltetrahydropyranone

C13H22O4 (242.1518)


   

Ac,Me ester-10-Hydroxy-8-decenoic acid

Ac,Me ester-10-Hydroxy-8-decenoic acid

C13H22O4 (242.1518)


   

CCC(=O)C(O)CC(=O)C(CC)=CCC(C)O

CCC(=O)C(O)CC(=O)C(CC)=CCC(C)O

C13H22O4 (242.1518)


   

Dibutyl itaconate

Dibutyl itaconate

C13H22O4 (242.1518)


   

deglucosyl euphorbioside A

deglucosyl euphorbioside A

C13H22O4 (242.1518)


   

(4aS),( 10bS)-7-amino-3,4,4a,5,6,10b-hexahydro-2,4-dimethyl-6-oxobenzo[f]quinoline

(4aS),( 10bS)-7-amino-3,4,4a,5,6,10b-hexahydro-2,4-dimethyl-6-oxobenzo[f]quinoline

C15H18N2O (242.1419)


   

2,5,6-Trihydroxy-7-megastigmen-9-one|trihydroxy-beta-ionone

2,5,6-Trihydroxy-7-megastigmen-9-one|trihydroxy-beta-ionone

C13H22O4 (242.1518)


   

2-methylpropane-1,3-diyl 1-((Z)-2-methyl-2-butenoate) 3-isobutyrate

2-methylpropane-1,3-diyl 1-((Z)-2-methyl-2-butenoate) 3-isobutyrate

C13H22O4 (242.1518)


   

HuperzineA

(+/-)-Huperzine A

C15H18N2O (242.1419)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors relative retention time with respect to 9-anthracene Carboxylic Acid is 0.361 D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents D004791 - Enzyme Inhibitors relative retention time with respect to 9-anthracene Carboxylic Acid is 0.348 (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease.

   

C13H22O4_6-Oxabicyclo[3.2.1]octane-3,8-diol, 8-[(1E)-3-hydroxy-1-buten-1-yl]-1,5-dimethyl

NCGC00385897-01_C13H22O4_6-Oxabicyclo[3.2.1]octane-3,8-diol, 8-[(1E)-3-hydroxy-1-buten-1-yl]-1,5-dimethyl-

C13H22O4 (242.1518)


   

C13H22O4_(3E)-4-(1,2,4-Trihydroxy-2,6,6-trimethylcyclohexyl)-3-buten-2-one

NCGC00384973-01_C13H22O4_(3E)-4-(1,2,4-Trihydroxy-2,6,6-trimethylcyclohexyl)-3-buten-2-one

C13H22O4 (242.1518)


   
   

(Z)-2-octylpent-2-enedioic acid

(Z)-2-octylpent-2-enedioic acid

C13H22O4 (242.1518)


   

Huperzin A

(±)-Huperzine A

C15H18N2O (242.1419)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2242 D020011 - Protective Agents D004791 - Enzyme Inhibitors INTERNAL_ID 2242; CONFIDENCE Reference Standard (Level 1) (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease.

   
   

2-Carboxy-4-dodecanolide

5-octyl-2-oxooxolane-3-carboxylic acid

C13H22O4 (242.1518)


   

(3S,5R,6R,7E)-3,5,6-Trihydroxy-7-megastigmen-9-one

(3E)-4-(1,2,4-trihydroxy-2,6,6-trimethylcyclohexyl)but-3-en-2-one

C13H22O4 (242.1518)


   

Ieodomycin A

Methyl 3S,5R-dihydroxy-8-methyl-8E,10-undecadienoate

C13H22O4 (242.1518)


A natural product found in Bacillus species.

   

Pantheric acid F

10-ethoxy-2methylene-10-oxodecanoic acid

C13H22O4 (242.1518)


   

1-(7-methoxynaphthalen-1-yl)piperazine

1-(7-methoxynaphthalen-1-yl)piperazine

C15H18N2O (242.1419)


   

4-[2-(5-ethylpyridin-2-yl)ethoxy]aniline

4-[2-(5-ethylpyridin-2-yl)ethoxy]aniline

C15H18N2O (242.1419)


   

N-(TERT-BUTYL)-3-(2-HYDROXYPROPAN-2-YL)-5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOLE-1-CARBOXAMIDE

N-(TERT-BUTYL)-3-(2-HYDROXYPROPAN-2-YL)-5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOLE-1-CARBOXAMIDE

C10H18N4O3 (242.1379)


   

3-(dimethylaminomethyl)-1,2,3,9-tetrahydro-4h-carbazole-4-one

3-(dimethylaminomethyl)-1,2,3,9-tetrahydro-4h-carbazole-4-one

C15H18N2O (242.1419)


   

Bisfentidine

Bisfentidine

C14H18N4 (242.1531)


   

1-[4-(Cyclohexyloxy)phenyl]-1H-imidazole

1-[4-(Cyclohexyloxy)phenyl]-1H-imidazole

C15H18N2O (242.1419)


   

4-(piperidin-1-ylmethyl)-1H-quinolin-2-one

4-(piperidin-1-ylmethyl)-1H-quinolin-2-one

C15H18N2O (242.1419)


   

vinylmethylbis(methylethylketoximino)silane

vinylmethylbis(methylethylketoximino)silane

C11H22N2O2Si (242.145)


   
   

2-(6-methoxynaphthalen-2-yl)piperazine

2-(6-methoxynaphthalen-2-yl)piperazine

C15H18N2O (242.1419)


   

6-(4-Tert-butylphenoxy)pyridin-3-amine

5-AMINO-2-(4-TERT-BUTYLPHENOXY)PYRIDINE

C15H18N2O (242.1419)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor

   

[[[[3-(aminomethyl)phenyl]methyl]amino]methyl]phenol

[[[[3-(aminomethyl)phenyl]methyl]amino]methyl]phenol

C15H18N2O (242.1419)


   

1-Octylxy-2,3-difluorobenzene

1-Octylxy-2,3-difluorobenzene

C14H20F2O (242.1482)


   

1,3,2-Dioxaborinane,2,2-oxybis[5,5-dimethyl-

1,3,2-Dioxaborinane,2,2-oxybis[5,5-dimethyl-

C10H20B2O5 (242.1497)


   

1-(PIPERIDIN-4-YL)SPIRO[CYCLOPROPANE-1,3-INDOLIN]-2-ONE

1-(PIPERIDIN-4-YL)SPIRO[CYCLOPROPANE-1,3-INDOLIN]-2-ONE

C15H18N2O (242.1419)


   

1-[4-(1H-indol-3-yl)piperidin-1-yl]ethanone

1-[4-(1H-indol-3-yl)piperidin-1-yl]ethanone

C15H18N2O (242.1419)


   

5-CYCLOHEXYL-3-(P-TOLYL)-1,2,4-OXADIAZOLE

5-CYCLOHEXYL-3-(P-TOLYL)-1,2,4-OXADIAZOLE

C15H18N2O (242.1419)


   

trans-3-azido-1-boc-4-methoxypyrrolidine

trans-3-azido-1-boc-4-methoxypyrrolidine

C10H18N4O3 (242.1379)


   

1-METHYL-4-[4-(1H-PYRAZOL-5-YL)PHENYL]PIPERAZINE

1-METHYL-4-[4-(1H-PYRAZOL-5-YL)PHENYL]PIPERAZINE

C14H18N4 (242.1531)


   

2,2-[5-(Hydroxymethyl)-1,3-phenylene]bis(2-methylpropanenitrile)

2-[3-(1-Cyano-1-methylethyl)-5-(hydroxymethyl)phenyl]-2-methylpropanenitrile

C15H18N2O (242.1419)


   

3-[(2,5-DIMETHYLBENZYL)OXY]-6-METHYLPYRIDIN-2-AMINE

3-[(2,5-DIMETHYLBENZYL)OXY]-6-METHYLPYRIDIN-2-AMINE

C15H18N2O (242.1419)


   

2-(2-(tert-Butyl)phenoxy)pyridin-3-amine

2-(2-(tert-Butyl)phenoxy)pyridin-3-amine

C15H18N2O (242.1419)


   

1-(3-Methyl-1-phenyl-5-pyrazolyl)piperazine

1-(3-Methyl-1-phenyl-5-pyrazolyl)piperazine

C14H18N4 (242.1531)


   

2-N-[2-(2-aminoanilino)ethyl]benzene-1,2-diamine

2-N-[2-(2-aminoanilino)ethyl]benzene-1,2-diamine

C14H18N4 (242.1531)


   

DI(PROPYLENE GLYCOL) ALLYL ETHER METH-

DI(PROPYLENE GLYCOL) ALLYL ETHER METH-

C13H22O4 (242.1518)


   

tert-butyl ((3S,4S)-4-azidotetrahydro-2H-pyran-3-yl)carbamate

tert-butyl ((3S,4S)-4-azidotetrahydro-2H-pyran-3-yl)carbamate

C10H18N4O3 (242.1379)


   

4-(3,4-DIMETHYL-QUINOLIN-8-YLAMINO)-BUTAN-2-ONE

4-(3,4-DIMETHYL-QUINOLIN-8-YLAMINO)-BUTAN-2-ONE

C15H18N2O (242.1419)


   

diethyl 2-cyclohexylpropanedioate

diethyl 2-cyclohexylpropanedioate

C13H22O4 (242.1518)


   

4-N-(4,6-dimethylpyrimidin-2-yl)-4-N-ethylbenzene-1,4-diamine

4-N-(4,6-dimethylpyrimidin-2-yl)-4-N-ethylbenzene-1,4-diamine

C14H18N4 (242.1531)


   

3-(2-AMINO-4-METHYLPHENOXY)-N,N-DIMETHYLANILINE

3-(2-AMINO-4-METHYLPHENOXY)-N,N-DIMETHYLANILINE

C15H18N2O (242.1419)


   

2-[(4,4-Diethoxy-2-butyn-1-yl)oxy]tetrahydro-2H-pyr

2-[(4,4-Diethoxy-2-butyn-1-yl)oxy]tetrahydro-2H-pyr

C13H22O4 (242.1518)


   
   

Valyl-beta-naphthylamide

Valyl-beta-naphthylamide

C15H18N2O (242.1419)


   

N-(1H-indol-4-yl)cyclohexanecarboxamide

N-(1H-indol-4-yl)cyclohexanecarboxamide

C15H18N2O (242.1419)


   

6-dehydro-SCB2

6-dehydro-SCB2

C13H22O4 (242.1518)


   

CID 4369233

(±)-Huperzine A

C15H18N2O (242.1419)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents D004791 - Enzyme Inhibitors (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease.

   

8-[(E)-3-hydroxybut-1-enyl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-3,8-diol

8-[(E)-3-hydroxybut-1-enyl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-3,8-diol

C13H22O4 (242.1518)


   

N-[(E)-Cyclohexylmethylideneamino]-1H-benzimidazol-2-amine

N-[(E)-Cyclohexylmethylideneamino]-1H-benzimidazol-2-amine

C14H18N4 (242.1531)


   

N-(4-ethylphenyl)-3-(1-pyrrolyl)propanamide

N-(4-ethylphenyl)-3-(1-pyrrolyl)propanamide

C15H18N2O (242.1419)


   

5-(4-Cyclohexylphenyl)-1,2-dihydropyrazol-3-one

5-(4-Cyclohexylphenyl)-1,2-dihydropyrazol-3-one

C15H18N2O (242.1419)


   

(3R,4R)-4-(hydroxymethyl)-3-(6-methylheptanoyl)oxolan-2-one

(3R,4R)-4-(hydroxymethyl)-3-(6-methylheptanoyl)oxolan-2-one

C13H22O4 (242.1518)


A butan-4-olide that is gamma-butyrolactone with a 6-methylheptanoyl substituent at position 3 and a hydroxymethyl substituent at position 4 (the 3R,4R-stereoisomer).

   
   

1-[5-(2-hydroxybutyl)furan-2-yl]-3-methoxybutan-2-ol

1-[5-(2-hydroxybutyl)furan-2-yl]-3-methoxybutan-2-ol

C13H22O4 (242.1518)


   

(5e,7s)-5-propylidene-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one

(5e,7s)-5-propylidene-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one

C15H18N2O (242.1419)


   

4-(2,5-dihydroxycyclohexyl)-2-methylbut-2-en-1-yl acetate

4-(2,5-dihydroxycyclohexyl)-2-methylbut-2-en-1-yl acetate

C13H22O4 (242.1518)


   

7-amino-2,4-dimethyl-3h,4ah,5h,10bh-benzo[f]quinolin-6-one

7-amino-2,4-dimethyl-3h,4ah,5h,10bh-benzo[f]quinolin-6-one

C15H18N2O (242.1419)


   

(3r,4r,5s,6r)-4-hydroxy-6-[(1e)-3-hydroxy-3-methylpent-1-en-1-yl]-3,5-dimethyloxan-2-one

(3r,4r,5s,6r)-4-hydroxy-6-[(1e)-3-hydroxy-3-methylpent-1-en-1-yl]-3,5-dimethyloxan-2-one

C13H22O4 (242.1518)


   

(1s,9r,10r)-17-hydroxy-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-17-ium

(1s,9r,10r)-17-hydroxy-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-17-ium

[C16H20NO]+ (242.1545)


   

4-(1,3,6-trihydroxy-2,2,6-trimethylcyclohexyl)but-3-en-2-one

4-(1,3,6-trihydroxy-2,2,6-trimethylcyclohexyl)but-3-en-2-one

C13H22O4 (242.1518)


   

2,5,6-trihydroxy-7-megastigmen-9-one

NA

C13H22O4 (242.1518)


{"Ingredient_id": "HBIN004583","Ingredient_name": "2,5,6-trihydroxy-7-megastigmen-9-one","Alias": "NA","Ingredient_formula": "C13H22O4","Ingredient_Smile": "NA","Ingredient_weight": "242.31","OB_score": "NA","CAS_id": "135447-37-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8872","PubChem_id": "NA","DrugBank_id": "NA"}

   

annuionone f

NA

C13H22O4 (242.1518)


{"Ingredient_id": "HBIN016244","Ingredient_name": "annuionone f","Alias": "NA","Ingredient_formula": "C13H22O4","Ingredient_Smile": "CC1CC(=O)CC(C1(C=CC(C)O)O)(C)CO","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1337","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

5-(4,6-dihydroxy-6-methyloctyl)-5h-furan-2-one

5-(4,6-dihydroxy-6-methyloctyl)-5h-furan-2-one

C13H22O4 (242.1518)


   

(1s,3s,5s,8r)-8-[(1e,3r)-3-hydroxybut-1-en-1-yl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-3,8-diol

(1s,3s,5s,8r)-8-[(1e,3r)-3-hydroxybut-1-en-1-yl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-3,8-diol

C13H22O4 (242.1518)


   

(3r,4s,5r)-4-hydroxy-4-[(1e,3r)-3-hydroxybut-1-en-1-yl]-3-(hydroxymethyl)-3,5-dimethylcyclohexan-1-one

(3r,4s,5r)-4-hydroxy-4-[(1e,3r)-3-hydroxybut-1-en-1-yl]-3-(hydroxymethyl)-3,5-dimethylcyclohexan-1-one

C13H22O4 (242.1518)


   

8-(3-hydroxybut-1-en-1-yl)-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-2,3-diol

8-(3-hydroxybut-1-en-1-yl)-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-2,3-diol

C13H22O4 (242.1518)


   

(1s,2r,3r,5r,8r)-8-[(1e,3r)-3-hydroxybut-1-en-1-yl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-2,3-diol

(1s,2r,3r,5r,8r)-8-[(1e,3r)-3-hydroxybut-1-en-1-yl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-2,3-diol

C13H22O4 (242.1518)


   

1-[5-(1-methoxypentyl)furan-2-yl]propane-1,2-diol

1-[5-(1-methoxypentyl)furan-2-yl]propane-1,2-diol

C13H22O4 (242.1518)


   

1-amino-13-ethenyl-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

1-amino-13-ethenyl-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

C15H18N2O (242.1419)


   

(13e)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

(13e)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

C15H18N2O (242.1419)


   

(7e)-7-ethyl-4,10-dihydroxyundec-7-ene-3,6-dione

(7e)-7-ethyl-4,10-dihydroxyundec-7-ene-3,6-dione

C13H22O4 (242.1518)


   

(2s,3r)-1-[(1r,4r,5r,8s)-1,8-dimethyl-2,7-dioxabicyclo[3.2.1]octan-4-yl]-3-hydroxy-2-methylbutan-1-one

(2s,3r)-1-[(1r,4r,5r,8s)-1,8-dimethyl-2,7-dioxabicyclo[3.2.1]octan-4-yl]-3-hydroxy-2-methylbutan-1-one

C13H22O4 (242.1518)


   

(5s)-5-hydroxy-5-(7-hydroxy-6-methyloctyl)furan-2-one

(5s)-5-hydroxy-5-(7-hydroxy-6-methyloctyl)furan-2-one

C13H22O4 (242.1518)


   

(1r,9r,13e)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

(1r,9r,13e)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

C15H18N2O (242.1419)


   

(5s)-5-(4,6-dihydroxy-6-methyloctyl)-5h-furan-2-one

(5s)-5-(4,6-dihydroxy-6-methyloctyl)-5h-furan-2-one

C13H22O4 (242.1518)


   

5-(6,7-dihydroxy-6-methyloctyl)-5h-furan-2-one

5-(6,7-dihydroxy-6-methyloctyl)-5h-furan-2-one

C13H22O4 (242.1518)


   

1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

C15H18N2O (242.1419)


   

4-hydroxy-4-(3-hydroxybut-1-en-1-yl)-3-(hydroxymethyl)-3,5-dimethylcyclohexan-1-one

4-hydroxy-4-(3-hydroxybut-1-en-1-yl)-3-(hydroxymethyl)-3,5-dimethylcyclohexan-1-one

C13H22O4 (242.1518)


   

(4r)-4-(hydroxymethyl)-3-(6-methylheptanoyl)oxolan-2-one

(4r)-4-(hydroxymethyl)-3-(6-methylheptanoyl)oxolan-2-one

C13H22O4 (242.1518)


   

n-{2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]ethylidene}hydroxylamine

n-{2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]ethylidene}hydroxylamine

C15H18N2O (242.1419)


   

(5s)-5-(6,7-dihydroxy-6-methyloctyl)-5h-furan-2-one

(5s)-5-(6,7-dihydroxy-6-methyloctyl)-5h-furan-2-one

C13H22O4 (242.1518)


   

(2e)-4-[(1r,2s,5r)-2,5-dihydroxycyclohexyl]-2-methylbut-2-en-1-yl acetate

(2e)-4-[(1r,2s,5r)-2,5-dihydroxycyclohexyl]-2-methylbut-2-en-1-yl acetate

C13H22O4 (242.1518)


   

ethyl 8-(3-formyloxiran-2-yl)octanoate

ethyl 8-(3-formyloxiran-2-yl)octanoate

C13H22O4 (242.1518)


   

(2e)-4-[(1r,2s,5s)-2,5-dihydroxycyclohexyl]-2-methylbut-2-en-1-yl acetate

(2e)-4-[(1r,2s,5s)-2,5-dihydroxycyclohexyl]-2-methylbut-2-en-1-yl acetate

C13H22O4 (242.1518)


   

(1r,9r,13r)-1-amino-13-ethenyl-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

(1r,9r,13r)-1-amino-13-ethenyl-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

C15H18N2O (242.1419)


   

1-{1,8-dimethyl-2,7-dioxabicyclo[3.2.1]octan-4-yl}-3-hydroxy-2-methylbutan-1-one

1-{1,8-dimethyl-2,7-dioxabicyclo[3.2.1]octan-4-yl}-3-hydroxy-2-methylbutan-1-one

C13H22O4 (242.1518)


   

(1r,9s,13z)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

(1r,9s,13z)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

C15H18N2O (242.1419)


   

(5s)-5-hydroxy-5-(6-hydroxy-6-methyloctyl)furan-2-one

(5s)-5-hydroxy-5-(6-hydroxy-6-methyloctyl)furan-2-one

C13H22O4 (242.1518)


   

(2,3-dimethyl-6-oxooxan-4-yl)methyl 2-methylbutanoate

(2,3-dimethyl-6-oxooxan-4-yl)methyl 2-methylbutanoate

C13H22O4 (242.1518)


   

5-methyl-4-oxo-2-(3-oxobutan-2-yl)heptyl formate

5-methyl-4-oxo-2-(3-oxobutan-2-yl)heptyl formate

C13H22O4 (242.1518)


   

n-[(2-aminophenyl)methyl]-2-(methoxymethyl)aniline

n-[(2-aminophenyl)methyl]-2-(methoxymethyl)aniline

C15H18N2O (242.1419)


   

methyl 3,5-dihydroxy-8-methylundeca-8,10-dienoate

methyl 3,5-dihydroxy-8-methylundeca-8,10-dienoate

C13H22O4 (242.1518)


   

ethyl 8-[(2r,3s)-3-formyloxiran-2-yl]octanoate

ethyl 8-[(2r,3s)-3-formyloxiran-2-yl]octanoate

C13H22O4 (242.1518)


   

(2s,3r)-1-[(3r,3ar,4s,5s,6ar)-4,5-dimethyl-hexahydrofuro[2,3-b]furan-3-yl]-3-hydroxy-2-methylbutan-1-one

(2s,3r)-1-[(3r,3ar,4s,5s,6ar)-4,5-dimethyl-hexahydrofuro[2,3-b]furan-3-yl]-3-hydroxy-2-methylbutan-1-one

C13H22O4 (242.1518)


   

7-ethyl-4,9-dihydroxyundec-7-ene-3,6-dione

7-ethyl-4,9-dihydroxyundec-7-ene-3,6-dione

C13H22O4 (242.1518)


   

7-ethyl-4,10-dihydroxyundec-7-ene-3,6-dione

7-ethyl-4,10-dihydroxyundec-7-ene-3,6-dione

C13H22O4 (242.1518)


   

(e)-n-{2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]ethylidene}hydroxylamine

(e)-n-{2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]ethylidene}hydroxylamine

C15H18N2O (242.1419)


   

(3e)-4-[(1r,3s,6r)-1,3,6-trihydroxy-2,2,6-trimethylcyclohexyl]but-3-en-2-one

(3e)-4-[(1r,3s,6r)-1,3,6-trihydroxy-2,2,6-trimethylcyclohexyl]but-3-en-2-one

C13H22O4 (242.1518)


   

8-(3-hydroxybut-1-en-1-yl)-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-3,8-diol

8-(3-hydroxybut-1-en-1-yl)-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-3,8-diol

C13H22O4 (242.1518)


   

(1r)-1-[(2s,5r)-5-(hydroxymethyl)oxolan-2-yl]-2-(pent-2-en-1-ylidene)propane-1,3-diol

(1r)-1-[(2s,5r)-5-(hydroxymethyl)oxolan-2-yl]-2-(pent-2-en-1-ylidene)propane-1,3-diol

C13H22O4 (242.1518)


   

1-{4,5-dimethyl-hexahydrofuro[2,3-b]furan-3-yl}-3-hydroxy-2-methylbutan-1-one

1-{4,5-dimethyl-hexahydrofuro[2,3-b]furan-3-yl}-3-hydroxy-2-methylbutan-1-one

C13H22O4 (242.1518)


   

4-hydroxy-6-(3-hydroxy-3-methylpent-1-en-1-yl)-3,5-dimethyloxan-2-one

4-hydroxy-6-(3-hydroxy-3-methylpent-1-en-1-yl)-3,5-dimethyloxan-2-one

C13H22O4 (242.1518)


   

[(2s,3r,4r)-2,3-dimethyl-6-oxooxan-4-yl]methyl 2-methylbutanoate

[(2s,3r,4r)-2,3-dimethyl-6-oxooxan-4-yl]methyl 2-methylbutanoate

C13H22O4 (242.1518)